Poniard Finds Cash to Keep Lights On: BioBuzz
A failed drug test last week had put Poniard in a cash-crunch situation.
12:59PM 11/23/09
Healthcare Stocks: Safe and Speculative
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio.
12:56PM 11/23/09
A Pair of Updates (Stocks Under $10 $)
Two model portfolio names are in the news today amid chatter on an obesity-drug study and a takeout rumor.
12:28PM 11/23/09
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
Shareholders are on the hook for a generous loan repayment to Cel-Sci's founder.
10:14AM 11/23/09
FDA Issues New Obesity Drug Heart Warning: BioBuzz
Safety of Abbott's Meridia may heighten concerns for all weight-loss drugs
08:15AM 11/23/09
Catch up on Jim Cramer's thinking on the hottest topics of the past week.
10:00AM 11/21/09
Weekly Roundup (Action Alerts PLUS $)
We took advantage of pullbacks to add to some core positions.
07:05PM 11/20/09
Tech Unfazed by Dismal Dell (RealMoney.com $)
Also, health care remains the top story, and ag is set for more gains.
04:19PM 11/20/09
'Fast Money' Recap: Playing Defense
The trading panel discussed moves for a market that is shifting to the downside.
07:46PM 11/19/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
How to Value a Middling Market (RealMoney.com $)
When the overall market is OK but not great, look closer at individual stocks.
12:52PM 11/19/09
'Mad Money' Recap: Cash for Caulkers
Cramer tells investors which trades would work on an intriguing stimulus program that would reward people for weatherizing their homes.
06:42PM 11/18/09
Sector Snap: UBS Upbeat On Medical Tech Stocks
Analyst upgrades Boston Scientific and Zimmer, lifts estimates on peers citing decreased risk
01:26PM 11/18/09
Trading Higher in a Down Market
NEW YORK (TheStreet) -- Portfolio Manager David Peltier discusses two low-dollar stocks that are bucking the market trend on Tuesday.
01:15PM 11/17/09
Int. Trade, Big Pharma and Beleaguered Banks
Alix Steel hosts. Guests include John Maccarone, CEO of Textainer Group Holdings, Stephanie Link, director of research for Jim Cramer's Action Alerts Plus portfolio and Richard Suttmeier, chief market strategist at ValuEngine.com.
04:48PM 11/16/09



Connect with TheStreet